Keterangan
Cancer genomics plays a pivotal role in the management of cancers by providing comprehensive insights into the genetic alterations underlying tumor development. This field involves analyzing the DNA and genetic makeup of cancer cells, enabling a more personalized and targeted approach to diagnosis and treatment. By understanding the specific genetic mutations driving cancer growth, clinicians can tailor therapies to target these specific abnormalities, leading to more effective and less toxic treatments. Additionally, cancer genomics facilitates the identification of potential biomarkers for early detection and prognosis, ushering in a new era of precision medicine that holds the promise of improved outcomes for cancer patients.
Ringkasan
- Dr. Subbarnath hosted a webinar on cancer genomics, highlighting its significance in cancer management. He emphasized Medvasiji's dedication to informing healthcare professionals about the latest advancements in the field. The webinar featured Dr. K.T. Gautam Reddyser, an expert in oncology, who shared insights on recent research, treatments, and best practices.
- Dr. Gautam began by stressing that while a complete cure for cancer remains elusive in many cases, effective management strategies have significantly improved patient outcomes and lifespan. He outlined a systematic approach to problem-solving in medicine: identifying the problem, developing remedies, testing them, and implementing successful solutions. This mirrors the evolution of treating diabetes from a fatal condition to a manageable one with insulin.
- The discussion progressed from viewing cancer as a disease of the body to understanding it as a disease of genomics. This evolution encompasses initial beliefs about whole-body ailments addressed through rituals, to focusing on affected tissues surgically, then targeting cells with chemotherapy, and finally, focusing on genetic mutations and genomic interactions. This transition reflects advancements in understanding the molecular basis of cancer.
- Dr. Gautam explained the molecular basis of cancer, beginning with non-lethal genetic damage that allows cells to survive with defects. He differentiated between driver and passenger mutations, emphasizing that driver mutations are responsible for the hallmarks of cancer, like uncontrolled growth and evasion of cell death. Epigenetic changes, such as DNA methylation, and clonal expansion of cancer cells also contribute to tumor progression.
- Cancer diagnosis involves a series of steps, starting with a biopsy followed by histological analysis, immunohistochemistry, flow cytometry, and molecular analysis. Immunohistochemistry identifies the origin of cancer cells by detecting specific proteins, while flow cytometry is used for liquid tumors. Molecular diagnostics analyze DNA for diagnosis, prognosis, minimal residual disease detection, and therapy guidance, including molecular profiling that assesses the entire genome.
- Dr. Gautam explained synthetic lethality, a strategy where a drug sensitizes cancer cells to another treatment, making them more susceptible to death. He used the example of parp inhibitors in BRCA-deficient ovarian cancer cells. Questions were asked about next-generation sequencing and copy number alterations in cancer genomics, which he explained are essential for determining drug targets and identifying specific genetic amplifications like HER2 in breast cancer.
- Addressing the challenge of intra-tumor heterogeneity, Dr. Gautam noted that cancer genomics helps identify variations, but strategies to address it involve multiple treatment modalities and targeting major contributing factors to cancer development. He acknowledged the importance of both clinical application and pure science in cancer genomics. He was unable to answer a question about tremotic methods, remove trim duplicators due to its specialty, but expressed interest in exploring the topic later.
Contoh Sertifikat
Tentang Pembicara
Dokter KC Goutham Reddy
Konsultan Senior Onkologi Medis, Karkinos Healthcare, Hyderabad
Komentar
Komentar
Anda harus login untuk meninggalkan komentar.